These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 32174823)

  • 1. Limited Sampling Modeling for Estimation of Phenotypic Metrics for CYP Enzymes and the ABCB1 Transporter Using a Cocktail Approach.
    Coelho EB; Cusinato DAC; Ximenez JP; Lanchote VL; Struchiner CJ; Suarez-Kurtz G
    Front Pharmacol; 2020; 11():22. PubMed ID: 32174823
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of potential herbal-drug interactions of a standardized propolis extract (EPP-AF®) using an in vivo cocktail approach.
    Cusinato DAC; Martinez EZ; Cintra MTC; Filgueira GCO; Berretta AA; Lanchote VL; Coelho EB
    J Ethnopharmacol; 2019 Dec; 245():112174. PubMed ID: 31442620
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LC-MS/MS analysis of the plasma concentrations of a cocktail of 5 cytochrome P450 and P-glycoprotein probe substrates and their metabolites using subtherapeutic doses.
    Cusinato DAC; Filgueira GCO; Rocha A; Cintra MACT; Lanchote VL; Coelho EB
    J Pharm Biomed Anal; 2019 Feb; 164():430-441. PubMed ID: 30445356
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined phenotypic assessment of CYP1A2, CYP2C19, CYP2D6, CYP3A, N-acetyltransferase-2, and xanthine oxidase with the "Cooperstown cocktail".
    Streetman DS; Bleakley JF; Kim JS; Nafziger AN; Leeder JS; Gaedigk A; Gotschall R; Kearns GL; Bertino JS
    Clin Pharmacol Ther; 2000 Oct; 68(4):375-83. PubMed ID: 11061577
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of Cytochrome P450 Inhibition and Induction on the Phenotyping Metrics of the Basel Cocktail: A Randomized Crossover Study.
    Derungs A; Donzelli M; Berger B; Noppen C; Krähenbühl S; Haschke M
    Clin Pharmacokinet; 2016 Jan; 55(1):79-91. PubMed ID: 26123704
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of Plasmodium vivax malaria and antimalarial treatment on cytochrome P450 activity in Brazilian patients.
    Almeida AC; Elias ABR; Marques MP; de Melo GC; da Costa AG; Figueiredo EFG; Brasil LW; Rodrigues-Soares F; Monteiro WM; de Lacerda MVG; Lanchote VL; Suarez-Kurtz G
    Br J Clin Pharmacol; 2021 Apr; 87(4):1859-1868. PubMed ID: 32997351
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined phenotypic assessment of cytochrome p450 1A2, 2C9, 2C19, 2D6, and 3A, N-acetyltransferase-2, and xanthine oxidase activities with the "Cooperstown 5+1 cocktail".
    Chainuvati S; Nafziger AN; Leeder JS; Gaedigk A; Kearns GL; Sellers E; Zhang Y; Kashuba AD; Rowland E; Bertino JS
    Clin Pharmacol Ther; 2003 Nov; 74(5):437-47. PubMed ID: 14586384
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of the "Inje cocktail" for high-throughput evaluation of five human cytochrome P450 isoforms in vivo.
    Ryu JY; Song IS; Sunwoo YE; Shon JH; Liu KH; Cha IJ; Shin JG
    Clin Pharmacol Ther; 2007 Nov; 82(5):531-40. PubMed ID: 17392720
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of cytochrome P450 activity by a five-drug cocktail approach.
    Zhu B; Ou-Yang DS; Chen XP; Huang SL; Tan ZR; He N; Zhou HH
    Clin Pharmacol Ther; 2001 Nov; 70(5):455-61. PubMed ID: 11719732
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of Mutual Drug-Drug Interaction within Geneva Cocktail for Cytochrome P450 Phenotyping using Innovative Dried Blood Sampling Method.
    Bosilkovska M; Samer C; Déglon J; Thomas A; Walder B; Desmeules J; Daali Y
    Basic Clin Pharmacol Toxicol; 2016 Sep; 119(3):284-90. PubMed ID: 27009433
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lisdexamfetamine Dimesylate Effects on the Pharmacokinetics of Cytochrome P450 Substrates in Healthy Adults in an Open-Label, Randomized, Crossover Study.
    Ermer J; Corcoran M; Martin P
    Drugs R D; 2015 Jun; 15(2):175-85. PubMed ID: 25862215
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lack of Effect of 12-Week Treatment with Risankizumab on the Pharmacokinetics of Cytochrome P450 Probe Substrates in Patients with Moderate to Severe Chronic Plaque Psoriasis.
    Khatri A; Cheng L; Camez A; Ignatenko S; Pang Y; Othman AA
    Clin Pharmacokinet; 2019 Jun; 58(6):805-814. PubMed ID: 30574672
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of Omeprazole Limited Sampling Strategies to Estimate Constitutive Cytochrome P450 2C19 Activity in Healthy Adults.
    Lin S; Nikanjam M; Capparelli EV; Allegrini A; Pavone D; Yim DS; Hammami MM; Bertino JS; Nafziger AN; Park YS; Kang JS; Yin OQ; Ma JD
    Ther Drug Monit; 2018 Dec; 40(6):754-758. PubMed ID: 30045358
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A limited sampling strategy based on maximum a posteriori Bayesian estimation for a five-probe phenotyping cocktail.
    Nguyen TT; Bénech H; Pruvost A; Lenuzza N
    Eur J Clin Pharmacol; 2016 Jan; 72(1):39-51. PubMed ID: 26490357
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fasting-Induced Changes in Hepatic P450 Mediated Drug Metabolism Are Largely Independent of the Constitutive Androstane Receptor CAR.
    de Vries EM; Lammers LA; Achterbergh R; Klümpen HJ; Mathot RA; Boelen A; Romijn JA
    PLoS One; 2016; 11(7):e0159552. PubMed ID: 27434302
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Simultaneous pharmacokinetics assessment of caffeine, warfarin, omeprazole, metoprolol, and midazolam intravenously or orally administered to Microminipigs.
    Mogi M; Toda A; Iwasaki K; Kusumoto S; Takehara H; Shimizu M; Murayama N; Izumi H; Utoh M; Yamazaki H
    J Toxicol Sci; 2012; 37(6):1157-64. PubMed ID: 23208431
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of Short-Term Fasting on Systemic Cytochrome P450-Mediated Drug Metabolism in Healthy Subjects: A Randomized, Controlled, Crossover Study Using a Cocktail Approach.
    Lammers LA; Achterbergh R; van Schaik RHN; Romijn JA; Mathôt RAA
    Clin Pharmacokinet; 2017 Oct; 56(10):1231-1244. PubMed ID: 28229374
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of disease-mediated therapeutic protein-drug interactions between an anti-interleukin-6 monoclonal antibody (sirukumab) and cytochrome P450 activities in a phase 1 study in patients with rheumatoid arthritis using a cocktail approach.
    Zhuang Y; de Vries DE; Xu Z; Marciniak SJ; Chen D; Leon F; Davis HM; Zhou H
    J Clin Pharmacol; 2015 Dec; 55(12):1386-94. PubMed ID: 26054042
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Simultaneous pharmacokinetics evaluation of human cytochrome P450 probes, caffeine, warfarin, omeprazole, metoprolol and midazolam, in common marmosets (Callithrix jacchus).
    Uehara S; Inoue T; Utoh M; Toda A; Shimizu M; Uno Y; Sasaki E; Yamazaki H
    Xenobiotica; 2016; 46(2):163-8. PubMed ID: 26114209
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prediction of the Area under the Curve Using Limited-Point Blood Sampling in a Cocktail Study to Assess Multiple CYP Activities.
    Miura M; Tanaka S; Uchida S; Kamiya C; Katayama N; Hakamata A; Odagiri K; Inui N; Kawakami J; Watanabe H; Namiki N
    Biol Pharm Bull; 2021; 44(6):762-770. PubMed ID: 34078808
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.